We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLED icon
2026
Universal Display
OLED
$3.85B
$9K ﹤0.01%
45
– –
OTTR icon
2027
Otter Tail
OTTR
$3.93B
$9K ﹤0.01%
179
+46
+35% +$2.39K
PARR icon
2028
Par Pacific Holdings
PARR
$3.97B
$9K ﹤0.01%
405
+164
+68% +$3.91K
PRK icon
2029
Park National Corp
PRK
$3.75B
$9K ﹤0.01%
95
– –
ROBO icon
2030
ROBO Global Robotics & Automation Index ETF
ROBO
$1.91B
$9K ﹤0.01%
230
– –
SBIO icon
2031
ALPS Medical Breakthroughs ETF
SBIO
$202M
$9K ﹤0.01%
215
-100
-32% -$3.71K
SF
2032
Stifel
SF
$12.8B
$9K ﹤0.01%
351
-14,645
-98% -$383K
THG icon
2033
Hanover Insurance
THG
$7.84B
$9K ﹤0.01%
71
-54
-43% -$7.27K
THS
2034
DELISTED
Treehouse Foods
THS
$9K ﹤0.01%
197
+102
+107% +$5.22K
VIS icon
2035
Vanguard Industrials ETF
VIS
$8.22B
$9K ﹤0.01%
+62
New +$9.33K
RPT
2036
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$9K ﹤0.01%
635
+267
+73% +$3.81K
NXGN
2037
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$9K ﹤0.01%
614
+177
+41% +$2.92K
NEX
2038
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$9K ﹤0.01%
+1,383
New +$7.46K
DDF
2039
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$9K ﹤0.01%
600
– –
MDP
2040
DELISTED
Meredith Corporation
MDP
$9K ﹤0.01%
315
+273
+650% +$9.71K
PRAH
2041
DELISTED
PRA Health Sciences, Inc.
PRAH
$9K ﹤0.01%
82
-185
-69% -$19K
BMCH
2042
DELISTED
BMC Stock Holdings, Inc
BMCH
$9K ﹤0.01%
319
+70
+28% +$1.97K
SUBC
2043
DELISTED
SUBSEA 7 S A SPONSORED ADR
SUBC
$9K ﹤0.01%
833
– –
AEB
2044
DELISTED
Aegon NV 5.29964% Floating Rate Perpetual Capital Securities
AEB
$9K ﹤0.01%
+385
New +$9.33K
AMCX icon
2045
AMC Global Media
AMCX
$451M
$8K ﹤0.01%
206
– –
ANGO icon
2046
AngioDynamics
ANGO
$593M
$8K ﹤0.01%
547
-410
-43% -$6.26K
BATRA icon
2047
Atlanta Braves Holdings Series A
BATRA
$3.53B
$8K ﹤0.01%
313
– –
CATY icon
2048
Cathay General Bancorp
CATY
$4.25B
$8K ﹤0.01%
236
-709
-75% -$25.9K
CIO
2049
DELISTED
City Office REIT
CIO
$8K ﹤0.01%
707
+571
+420% +$7.62K
CLVT icon
2050
Clarivate
CLVT
$1.53B
$8K ﹤0.01%
500
– –
80 81
82
83 84

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.